Free Trial
Portfolio Monitoring Tools for the A.I. EraGet 30 Days Free

Zhengye Biotechnology (NASDAQ:ZYBT) Shares Gap Down - Here's What Happened

Written by MarketBeat
Updated September 15, 2025
Zhengye Biotechnology logo with Medical background

Key Points

  • Zhengye Biotechnology shares gapped down from a previous close of $9.82 to an opening of $9.49 before last trading at $10.76 with a volume of 54,010 shares.
  • Wall Street analysts raised Zhengye Biotechnology to a "hold" rating, indicating a neutral stance on the stock's performance.
  • Institutional investors have recently shown interest, with several firms, including Geode Capital Management and Invesco, acquiring new positions in Zhengye Biotechnology during the second quarter.
  • Interested in Zhengye Biotechnology? Here are five stocks we like better.

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT - Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $9.82, but opened at $9.49. Zhengye Biotechnology shares last traded at $10.76, with a volume of 54,010 shares.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded Zhengye Biotechnology to a "hold" rating in a research note on Saturday, August 2nd.

View Our Latest Analysis on ZYBT

Zhengye Biotechnology Stock Up 14.7%

The company's 50 day moving average price is $7.11 and its 200-day moving average price is $7.09. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.88 and a current ratio of 1.31.

Institutional Investors Weigh In On Zhengye Biotechnology

Several large investors have recently modified their holdings of the stock. Geode Capital Management LLC purchased a new stake in shares of Zhengye Biotechnology during the 2nd quarter valued at approximately $174,000. Invesco Ltd. purchased a new stake in shares of Zhengye Biotechnology during the 2nd quarter valued at approximately $220,000. Finally, Jane Street Group LLC purchased a new stake in shares of Zhengye Biotechnology during the 2nd quarter valued at approximately $1,158,000.

Zhengye Biotechnology Company Profile

(Get Free Report)

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.

See Also

Should You Invest $1,000 in Zhengye Biotechnology Right Now?

Before you consider Zhengye Biotechnology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zhengye Biotechnology wasn't on the list.

While Zhengye Biotechnology currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover
10 Best Stocks to Own: Fall 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.